The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Lee Valley Tools Ltd., et al. v. Sears, Roebuck & Co., et al.
Successfully represented Lee Valley Tools Ltd. in obtaining a U.S. patent and patent re-issuance for a power tool accessory, and successfully more
White et al. v. Experian Information Solutions Inc., et al.
Represents Equifax in this putative class action filed in the United States District Court for the Central District of California. The more
Board of Supervisors of Louisiana State University et al. v. Smack Apparel Co.
Represented four major universities and The Collegiate Licensing Company (CLC) in a trade dress infringement case. In an attempt to avoid the more
Over $200 million in Chapter 11 debtor-in-possession credit facilities to a national freight trucking company
Represented a commercial finance company as agent and lender in connection with over $200 million in Chapter 11 debtor-in-possession credit more